Feedback
I.D.: 103543358

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System

Vrsta ugovora
Service Contract
Datum objave
01/10/24
Vrsta objave:
Tender (all procedures)
 
 
Mjesto isporuke:
United States
  • Preuzmi
  • Printanje
  • Bilješke
    Morate biti prijavljeni kako biste mogli spremiti bilješke.
  • Proslijedi
  • Prijevod
Opis:
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Puni tekst:
Registrirajte se sada za 7-dnevni besplatni test i omogućite si pristup ovom i mnogim drugim tenderima iz Vaše branše!

Zašto tenderi.hr?

  • Individualizirane pretrage

  • Najopširnija baza tendera u Hrvatskoj

  • Osobni agent za korisničku podršku -
    čak i za vrijeme besplatnog testiranja!

  • Dnevna dostava novih tendera

Moja registracija

Pogledajte slične tendere

Naslov Rok
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System 18.08.27
Biologic-based Drug Discovery and Development for Disorders of the Nervous System 27.01.25
Biologic-based Drug Discovery and Development for Disorders of the Nervous System 27.01.25
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System 18.08.26
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders 07.05.26
Innovation Grants to Nurture Initial Translational Efforts Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery 20.10.27
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders 07.05.26
Assay development and screening for discovery of chemical probes, drugs or immunomodulators 07.09.26
Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug 05.04.25
Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug 05.04.25